Show simple item record

dc.contributor.advisorChumley, Michael
dc.contributor.authorVilas, Caitlyn
dc.date2020-05-19
dc.date.accessioned2020-08-24T15:56:25Z
dc.date.available2020-08-24T15:56:25Z
dc.date.issued2020
dc.identifier.urihttps://repository.tcu.edu/handle/116099117/40291
dc.description.abstractAlzheimer's Disease (AD) is a neurodegenerative disease that afflicts the elderly. Three hallmark pathologies of AD include amyloid beta (A-beta) accumulation, inflammation, and oxidative stress. The aggregation of A-beta protein fragments develops plaques in the brain, increasing levels of proinflammatory cytokines. Chronic activation of proinflammatory cytokines increases inflammation, further exacerbating AD pathologies. Oxidative stress is linked to many neurodegenerative diseases, due to an imbalance of the antioxidant system and increased reactive oxygen species (ROS) production, which further damages DNA and chronically activates microglial cells. Past research has shown that antioxidant compounds alleviate proinflammatory cytokine production. The aim of this study was to further explore this by studying the therapeutic capabilities of two potent antioxidant molecules (L2 and L4) in attenuating oxidative stress and inflammation in microglial cells. We hypothesized that L2 and L4 will reduce proinflammatory cytokines induced by LPS treatment.
dc.subjectAlzheimer's Disease
dc.subjectAntioxidant
dc.subjectBV2 microglial cells
dc.subjectInflammation
dc.subjectOxidative Stress
dc.titleThe Effects of Therapeutic Antioxidant Compounds on the Production of Proinflammatory Cytokines in BV2 Microglial Cells
etd.degree.departmentBiology
local.collegeCollege of Science and Engineering
local.collegeJohn V. Roach Honors College
local.departmentBiology


Files in this item

Thumbnail
This item appears in the following Collection(s)

Show simple item record